ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.718,07
0,65%
S&P 500
5.475,09
0,27%
US Dollar vs BRL
5,6565
1,13%
Bitcoin
62.847,73
0,40%
Brent Oil
86,53
1,67%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Ventyx Biosciences Inc (VTYX)

  7. Ventyx Biosciences Inc (VTYX) Notícias

VTYX

Ventyx Biosciences (VTYX)

Ventyx Biosciences Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:VTYX
DataHoraFonteTítuloCódigoCompanhia
11/06/202417:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VTYXVentyx Biosciences Inc
06/06/202417:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VTYXVentyx Biosciences Inc
05/06/202417:01GlobeNewswire Inc.Ventyx Biosciences Announces Positive Preclinical Data for CNS-Penetrant NLRP3 Inhibitor VTX3232 Demonstrating Reversal of Obesity and Improvements in Cardiometabolic and Inflammatory MarkersNASDAQ:VTYXVentyx Biosciences Inc
16/05/202417:05GlobeNewswire Inc.Ventyx Biosciences to Participate in Three Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
16/05/202409:00GlobeNewswire Inc.Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating OfficerNASDAQ:VTYXVentyx Biosciences Inc
09/05/202417:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VTYXVentyx Biosciences Inc
09/05/202417:01GlobeNewswire Inc.Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
02/05/202417:05GlobeNewswire Inc.Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:VTYXVentyx Biosciences Inc
26/04/202406:45PR Newswire (US)The Gross Law Firm Reminds Ventyx Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 30, 2024 - VTYXNASDAQ:VTYXVentyx Biosciences Inc
19/04/202407:00PR Newswire (US)Ventyx Biosciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
16/04/202406:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of April 30, 2024 in Ventyx Biosciences, Inc. Lawsuit - VTYXNASDAQ:VTYXVentyx Biosciences Inc
09/04/202407:10PR Newswire (US)Investors in Ventyx Biosciences, Inc. Should Contact The Gross Law Firm Before April 30, 2024 to Discuss Your Rights - VTYXNASDAQ:VTYXVentyx Biosciences Inc
05/04/202406:45PR Newswire (US)Investors who lost money on Ventyx Biosciences, Inc.(VTYX) should contact The Gross Law Firm about pending Class Action - VTYXNASDAQ:VTYXVentyx Biosciences Inc
26/03/202406:45PR Newswire (US)Ventyx Biosciences, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - VTYXNASDAQ:VTYXVentyx Biosciences Inc
11/03/202408:00GlobeNewswire Inc.Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio and Provides Pipeline Updates at Virtual Investor EventNASDAQ:VTYXVentyx Biosciences Inc
08/03/202418:05Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VTYXVentyx Biosciences Inc
07/03/202410:00GlobeNewswire Inc.Ventyx Biosciences Announces $100 Million Private Placement of Common StockNASDAQ:VTYXVentyx Biosciences Inc
07/03/202407:45PR Newswire (US)Class Action Filed Against Ventyx Biosciences, Inc. (VTYX) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:VTYXVentyx Biosciences Inc
06/03/202410:00GlobeNewswire Inc.Ventyx Biosciences to Participate in Two Upcoming Investor ConferencesNASDAQ:VTYXVentyx Biosciences Inc
04/03/202410:00GlobeNewswire Inc.Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024NASDAQ:VTYXVentyx Biosciences Inc
27/02/202418:01GlobeNewswire Inc.Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
22/02/202409:00GlobeNewswire Inc.Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002 in Ulcerative Colitis at the 19th Congress of the European Crohn's and Colitis Organisation (ECCO)NASDAQ:VTYXVentyx Biosciences Inc
13/02/202418:09Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNASDAQ:VTYXVentyx Biosciences Inc
06/02/202418:05GlobeNewswire Inc.Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VTYXVentyx Biosciences Inc
02/01/202418:47Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VTYXVentyx Biosciences Inc
20/12/202321:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VTYXVentyx Biosciences Inc
21/11/202318:05GlobeNewswire Inc.Ventyx Biosciences to Participate in the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:VTYXVentyx Biosciences Inc
10/11/202310:00GlobeNewswire Inc.Ventyx Biosciences to Participate in the Jefferies London Healthcare ConferenceNASDAQ:VTYXVentyx Biosciences Inc
09/11/202318:01GlobeNewswire Inc.Ventyx Biosciences Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate ProgressNASDAQ:VTYXVentyx Biosciences Inc
07/11/202308:33IH Market NewsKeep An Eye Out: Pre-Market Movers And Analyst RecommendationsNASDAQ:VTYXVentyx Biosciences Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:VTYX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
OIBR3
OI ON
BOV
NGRD3
Neogrid Participacoes ON
BOV
GFSA3
GAFISA ON
BOV
AZEV4
AZEVEDO PN
BOV
HAGA3
HAGA ON
BOV
BAZA3
AMAZONIA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
COGN3
COGNA ON
BOV
GOLL4
GOL PN
BOV
AMER3
Americanas ON
BOV
IDIV
Dividend
BOV
TPIS3
TRIUNFO PART ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
PRIO3
PETRORIO ON
BOV
CXSE3
Caixa Seguridade Partici... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados